Literature DB >> 2657629

Acromegaly in an infant.

D L Blumberg1, C A Sklar, R David, S Rothenberg, J Bell.   

Abstract

Serial hormonal studies were carried out in a girl with a growth hormone-secreting pituitary adenoma and hyperprolactinemia diagnosed at 21 months of age, the youngest verified case of acromegaly. The child had progressive macrocephaly, noted at 6 months of age, which preceded the rapid acceleration of linear growth by nearly 1 year. At 21 months of age, the girl's head circumference measured 55 cm (+5.5 SD) and her height was 97.6 cm (+4.4 SD). Preoperative serum growth hormone level was 135 ng/mL, somatomedin C was 1,540 ng/mL (normal for bone age 18 to 97 ng/mL), and prolactin was 370 ng/mL (normal less than 20 ng/mL). Following total resection of a large adenoma, immunohistochemical staining of the tumor showed growth hormone but not prolactin. With longitudinal monitoring of the child for 2 years postoperatively, persistently low growth hormone levels were demonstrated and normal growth velocity (6 cm/yr). Peak serum growth hormone levels ranged from 2.8 to 4.1 ng/mL after stimulation tests with insulin, arginine, and L-dopa. Maximum sleep-entrained growth hormone level was 3.4 ng/mL. At the same time, serum somatomedin C levels measured serially were normal (29 to 111 ng/mL), whereas simultaneous prolactin levels were moderately increased (30 to 147 ng/mL). The data support the hypothesis that hyperprolactinemia may have contributed to stimulating somatomedin C and sustaining the normal growth rate in this child.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657629

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Childhood acromegaly due to X-linked acrogigantism: long term follow-up.

Authors:  Rebecca J Gordon; Jennifer Bell; Wendy K Chung; Raphael David; Sharon E Oberfield; Sharon L Wardlaw
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

2.  Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother.

Authors:  Brittany K Wise-Oringer; George J Zanazzi; Rebecca J Gordon; Sharon L Wardlaw; Christopher William; Kwame Anyane-Yeboa; Wendy K Chung; Brenda Kohn; Jeffrey H Wisoff; Raphael David; Sharon E Oberfield
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

3.  Pathological and experimental investigations in a case of gigantism.

Authors:  I Fazekas; E Pásztor; F Slowik; K Bálint; I Dobronyi; E Bácsy; A Gyévai; F Péter; L Blatniczky; I Varga
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Acromegaly: an epidemiological study.

Authors:  J Etxabe; S Gaztambide; P Latorre; J A Vazquez
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

5.  Acromegaly in preadolescence: A case report of a 9-year-old boy with acromegaly.

Authors:  Tobechi Mbadugha; Toshihiro Ogiwara; Alhusain Nagm; Takatoshi Hasegawa; Keisuke Kamiya; Yuki Matsumoto; Mikiko Kobayashi; Kazuhiro Hongo
Journal:  Surg Neurol Int       Date:  2020-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.